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Abstract
A conditional-lethal recombinant virus was constructed in which the expression of the vaccinia
virus I7L gene is under the control of the tetracycline operator/repressor system. In the absence
of I7L expression, processing of the major VV core proteins is inhibited and electron microscopy
reveals defects in virion morphogenesis subsequent to the formation of immature virion particles
but prior to core condensation. Plasmid-borne I7L is capable of rescuing the growth of this virus
and rescue is optimal when the I7L gene is expressed using the authentic I7L promoter. Taken
together, these data suggest that correct temporal expression of the VV I7L cysteine proteinase is
required for core protein maturation, virion assembly and production of infectious progeny.
Proteolytic cleavage of precursor proteins is an essential
process in the life cycle of many viruses, including vac-
cinia virus (VV). The cysteine proteinase encoded by the
VV I7L gene, was originally identified based on a sequence
comparison with the African Swine Fever virus proteinase
and an ubiquitin-like proteinase in yeast [1,2]. We have
previously shown through trans processing assays that the
I7L gene product is capable of cleaving the core protein
precursors p4a, p4b, and p25K at conserved AG/X sites
and have used reverse genetics to identify active site resi-
dues [3,4]. To determine the role that the I7L proteinase
plays in the VV replication cycle, we report here the con-
struction and in vivo analysis of a VV mutant in which the
expression of the I7L gene can be conditionally regulated.
While this work was in progress, Ansarah-Sobrinho and
Moss [5] published a report demonstrating that the I7L
proteinase, in an inducible mutant virus regulated by the
lac  operator and driven off of the T7 promoter, was
responsible for cleaving the A17L membrane protein as
well as the L4R core protein precursor. In this work, we
show that I7L proteinase, in a different inducible mutant
virus, this one regulated by the tetracycline (TET) opera-
tor/repressor system and driven off of the I7L native pro-
moter, is responsible for cleaving the other core protein
precursors (p4a and p4b). We also demonstrate that
expression of the I7L gene from its native promoter
appears to be important for optimal viral assembly and
replication.
To investigate the role of the I7L proteinase in the viral life
cycle, an inducible mutant virus was constructed in which
the expression of the I7L gene could be regulated by the
presence or absence of TET using the components of the
bacterial tetracycline operon [6,7]. This system has been
shown to be successful in the regulation of the vaccinia
virus G1L [8,9] and A14L [10] genes. A plasmid was con-
structed containing the tetO just upstream of the I7L open
reading frame (ORF) in order to regulate expression of I7L
proteinase with TET in the presence of a tetracycline
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repressor (TetR). Also included was the genomic DNA
sequence from 250 bp upstream of the I7L ORF, to
include the native promoter, and to aid in homologous
recombination. This plasmid was used to create the
recombinant virus vtetOI7L using the transient dominant
selection method [11]. A commercially available cell line,
T-Rex-293 (Invitrogen), expressing the TetR was used to
regulate the expression of the I7L gene from the infecting
recombinant virus. This conditional-lethal expression sys-
tem has recently been used to show that the enzymatic
activity of the VV G1L metalloproteinase is essential for
viral replication [9].
The conditional-lethal phenotype of the recombinant
virus was shown by plaque assay (Fig. 1), in which the for-
mation of plaques from vtetOI7L is dependent on the
presence of TET, while the wild-type virus is unaffected by
either the presence or absence of TET. To determine the
optimum TET concentration required for replication of
vtetOI7L, TREx-293 cells were infected with vtetOI7L in
the presence of varying concentrations of TET, harvested
24 h later, and the titer determined on BSC40 cells [12]. A
2-log increase in viral yield was observed with 1 µg/ml
TET (data not shown). To confirm that expression of the
I7L gene was essential for viral replication, TREx-293 cells
were infected with vtetOI7L at a multiplicity of infection
(MOI) of 0.1, 0.5, 5, or 10 in the presence or absence of
TET, harvested 24 h later, and the titer of the virus infected
cell lysates determined on BSC40 cells. At an MOI of 0.1 or
0.5 there was an average reduction of 99.1% of infectious
virus particles (Fig. 2). At an MOI of 5 there was an aver-
age reduction of 95.7%, and at an MOI of 10 there was an
average reduction of 90.3% (Fig. 2). This multiplicity-
dependent breakthrough of viral replication is likely due
to gene copy overwhelming the amount of TetR being
expressed by the TREx-293 cell line.
To test whether the insertion of the TET operator just
upstream of the I7L ORF had an effect on the viral growth
kinetics, a one-step growth curve was conducted. TREx-
293 cells were infected with wild type virus or vtetOI7L in
the presence or absence of TET and infected cell lysates
were harvested at the indicated times and the titer deter-
mined on BSC40 cells (Fig. 3A). In the presence of TET, the
recombinant virus grew to the same yield and with the
same kinetics as wild type virus while in the absence of
TET the production of infectious virus was much lower
indicating that the presence of the TET operator did not
have an effect on the growth kinetics of the inducible
mutant virus.
To demonstrate that the replication defect of the vtetOI7L
mutant virus in the absence of TET was due to the I7L gene
we tested whether viral replication could be rescued by the
introduction of a plasmid-borne I7L gene. TREx-293 cells
in 6-well plates were transfected with 1.8 µg of plasmid
DNA (containing either no insert, a wild type I7L gene
under the control of the synthetic early-late promoter, a
I7L gene with the catalytic His241 mutated to Ala, or the
I7L gene under the control of its native promoter) and
infected with vtetOI7L at an MOI of 0.2 plaque-forming
units per cell in the absence of TET. Cells were harvested
24 hours post infection (hpi) and the titer determined on
BSC40 cells. As an additional control, TREx-293 cells were
mock transfected and infected with vtetOI7L in the pres-
ence of 1 µg/ml TET to compare growth conditions. A par-
tial rescue of viral replication was observed when cells
were transfected with the I7L gene under the control of the
synthetic early/late promoter, but not when cells were
transfected with plasmid alone or with a mutant I7L gene
(Fig. 3B). This was an approximate 5-fold increase in virus
replication compared to the pRB21 or pI7LH241A trans-
fected controls. When the I7L gene was driven off of its
own promoter in pCB26 and transfected in, there was a
much higher level of rescue (Fig. 3B), suggesting that the
timing and amount of I7L gene expression has important
implications for the viral life cycle.
We have previously shown through transient expression
assays that the I7L proteinase is capable of cleaving the
p4b, p4a, and p25k core protein precursors [3,4] which
are products of the A3L, A10L, and L4R open reading
frames respectively. Here we were interested to see
whether the I7L proteinase in the conditional lethal
Effect of TET on plaque formation Figure 1
Effect of TET on plaque formation. TREx-293 cells were 
infected with vtetOI7L or wild-type virus in the presence or 
absence of 1 µg/ml TET and harvested 24 hpi. BSC40 cells 
were then infected and stained with crystal violet 48 hpi.
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mutant system was also capable of cleaving these proteins
in the presence but not the absence of TET. First, to see
whether I7L protein was expressed at the same time from
the mutant virus as from the wild type virus, TREx-293
cells were infected in the presence of TET and cells har-
vested at various time points. Proteins in the crude cell
extracts were separated by SDS-PAGE and detected by
Western blot with anti-I7L antisera. I7L enzyme from both
Effect of TET on viral replication and rescue of the vtetOI7L mutant Figure 2
Effect of TET on viral replication and rescue of the vtetOI7L mutant. TREx-293 cells were infected with vtetOI7L in 
the absence (-) or presence of 1 µg/ml TET at an MOI of 0.1, 0.5, 5, or 10. Infected cells were harvested 24 hpi and titrated on 
BSC40 cells.
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viruses appeared at late times after infection, around 8 hpi
and increased as time progressed (data not shown). To
determine the effect of TET on I7L protein expression,
cells were infected and treated with 0 to 5 µg/ml TET. After
6 h, the infected cells were labeled with 60 µCi/ml 35S-met
and harvested after 24 h. Extracts were immunoprecipi-
tated with I7L antisera and protein detected by autoradi-
ography. With wild type virus, I7L protein was expressed
at each TET concentration (data not shown). However, in
the mutant virus, expression of I7L enzyme was repressed
in the absence of TET and increased with the addition of
TET.
To determine the effect of TET concentration on p4b core
protein precursor processing, cells were infected in the
presence of 0 to 5 µg/ml TET, harvested 24 hpi, and the
extracts immunoblotted with anti-4b antisera. With wild
type virus p4b was processed at each TET concentration as
expected, however with the mutant virus, p4b processing
was repressed in the absence of TET (data not shown). The
slight processing in the absence of TET is likely due to
slight leak-through of I7L gene expression in this system.
The same results were seen for the processing of p4a, with
processing in each of the wild type virus lanes, repressed
processing with the mutant in the absence of TET and
increased processing in the presence of TET (data not
shown). Kane and Shuman [13] have previously shown
that I7L protein is located in the virus core. To verify that
the I7L protein from the inducible mutant was localized
correctly, purified virions were treated with DTT and NP-
40 to separate the envelope fraction from the core fraction
and protein from each sample was separated by SDS-
PAGE and detected by Western blot with anti-I7L antisera.
As expected, the I7L enzyme from the inducible mutant
was detected in the core sample, as was the wild type virus
(data not shown).
The morphogenesis of vtetOI7L under nonpermissive
conditions was analyzed via electron microscopy. TREx-
293 cells were infected with vtetOI7L at an MOI of 1 in the
presence or absence of TET and harvested 24 h later. In the
presence of TET, cells contained a variety of both imma-
ture and mature forms of the virus (Fig. 4, panels A-C),
which were indistinguishable from cells infected with
wild type virus (not shown). However, in the absence of
TET, no mature virions were observed in any of the
infected cells observed. There appeared to be an accumu-
lation of immature viral particles, some with nucleoids, as
well as the appearance of crescent shaped particles (Fig. 4,
panels D-F), similar to those observed by Ansarah-
Sobrinho et al [5]. Also observed were numerous dense
virus particles. Virion morphogenesis appears to arrest at
a stage prior to core condensation. The observation that
there is still some processing of p4b in the absence of TET
and yet the morphology of the mutant virus in the
absence of TET shows only immature virus particles sug-
gests the hypothesis that there is a requirement for the
processing threshold of the core protein precursors to be
achieved before morphogenesis can proceed.
Taken together, the data we have presented here, as well as
analysis of the VV G1L conditional lethal mutant [9], sug-
gests a morphogenesis model in which these two putative
proteases operate sequentially to regulate assembly.
According to this model, if we assume that both I7L and
Panel A: One step growth curve Figure 3
Panel A: One step growth curve. TREx-293 cells were 
infected with wild-type virus (circle) or vtetOI7L in the pres-
ence (square) or absence (triangle) of 1 µg/ml TET. Infected 
cells were harvested at the indicated times and the titer 
determined on BSC40 cells. Panel B: Rescue of replica-
tion. TREx-293 cells were infected with vtetOI7L and trans-
fected with either vector alone (pRB21), plasmid with wild-
type I7L driven off of a synthetic early/late promoter (pI7L), 
plasmid with mutant I7L, mutated in the putative active site, 
driven off of a synthetic early/late promoter (pI7LH241A), or 
wild-type I7L driven off of its native promoter (pCB26) in the 
absence of TET. Infected cells were harvested 24 hpi and the 
titer determined on BSC40 cells. Transfection of plasmid 
borne wild-type I7L but not of mutant I7L or vector alone 
partially rescued the replication of vtetOI7L.
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G1L are associated with the immature virus along with the
accompanying DNA and other viral proteins, then activa-
tion of I7L leads to the process of core protein precursor
cleavage and the initiation of core condensation. Follow-
ing this activity, the activation of G1L completes core con-
densation and allows progression to the formation of
intracellular mature virus. If the activity of the I7L protei-
nase is blocked, viral morphogenesis arrests prior to core
condensation. If the activity of G1L proteinase is blocked,
viral morphogenesis arrests at a stage subsequent to this
but still prior to complete core condensation. To test this
model, it will be of interest to isolate biochemically active
I7L and G1L enzymes and determine the series of events
that lead to their activation.
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Electron microscopy of cells infected with vtetOI7L Figure 4
Electron microscopy of cells infected with vtetOI7L. TREx-293 cells were infected with vtetOI7L at an MOI of 1 in the 
presence (panels A, B, and C) of 10 µg/ml TET or in the absence (panels D, E, and F) of TET. Cells were harvested at 24 hpi, 
immediately fixed and prepared for transmission electron microscopy. The bar in panels A, B, D, E, and F represents 400 nm. 
The bar in panel C represents 200 nm.
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